Linked Life Data

11824310

Source:http://linkedlifedata.com/resource/pubmed/id/11824310

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2002-2-4
pubmed:abstractText
For life-threatening hemangiomas where surgical or laser techniques are not feasible, systemic therapy with cortisone or interferon represents the therapy of choice. With response rates of 80-90%, both drugs are equally effective. Both treatments, however, might be associated with severe side-effects. Among these the risk of interferon-induced neurotoxicity has to be given special mention. Thus, the indication for systemic therapy of hemangiomas has to be made carefully, weighing up risk and benefit.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1868-1050
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
516-20
pubmed:dateRevised
2007-4-24
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
[Systemic therapy of hemangioma].
pubmed:affiliation
Kinderklinik und Kinderpoliklinik im Dr. v. Haunerschen Kinderspital, Lindwurmstrasse 4, 80337 München.
pubmed:publicationType
Journal Article, English Abstract